The case for therapeutic vaccines.

Suppr

超能文献

作者信息

Dalgleish A

机构信息

Division of Oncology, Department of Cellular and Molecular Sciences, St. George's Hospital Medical School, London, UK.

出版信息

Melanoma Res. 1996 Feb;6(1):5-10. doi: 10.1097/00008390-199602000-00002.

DOI:10.1097/00008390-199602000-00002

PMID:8640070

Abstract

摘要

相似文献

The case for therapeutic vaccines.

Melanoma Res. 1996 Feb;6(1):5-10. doi: 10.1097/00008390-199602000-00002.

Active immunotherapy with allogeneic tumor cell vaccines: present status.

Semin Oncol. 1998 Dec;25(6):611-22.

The development of therapeutic vaccines of the management of malignant melanoma.

Cancer Surv. 1996;26:289-319.

Does adjuvant vaccine therapy really have activity in malignant melanoma?

J Clin Oncol. 2007 Oct 10;25(29):4693; author reply 4693-5. doi: 10.1200/JCO.2007.13.3389.

Rational development of peptide vaccination in clinical oncology.

Onkologie. 2001 Apr;24(2):174. doi: 10.1159/000050308.

Cancer vaccines get a shot in the arm.

Science. 1993 Nov 5;262(5135):841-3. doi: 10.1126/science.8235605.

Immunotherapeutic approaches for the treatment of malignant melanoma.

Curr Opin Investig Drugs. 2001 Nov;2(11):1553-63.

Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine.

Semin Cancer Biol. 2003 Dec;13(6):409-15. doi: 10.1016/j.semcancer.2003.09.004.

Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal.

J Am Coll Surg. 2008 Jul;207(1):95-105. doi: 10.1016/j.jamcollsurg.2008.01.024. Epub 2008 May 23.

Melanoma and immunotherapy.

Hematol Oncol Clin North Am. 2009 Jun;23(3):547-64, ix-x. doi: 10.1016/j.hoc.2009.03.009.

引用本文的文献

Gene therapy of benign gynecological diseases.

Adv Drug Deliv Rev. 2009 Aug 10;61(10):822-35. doi: 10.1016/j.addr.2009.04.023. Epub 2009 May 13.

Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.

Cancer Immunol Immunother. 2007 Nov;56(11):1853-60. doi: 10.1007/s00262-007-0340-1. Epub 2007 Jun 5.

Potential applications of gene therapy in the patient with cancer.

Drugs Aging. 2000 Aug;17(2):121-32. doi: 10.2165/00002512-200017020-00004.

Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Cancer Metastasis Rev. 1996 Sep;15(3):351-64. doi: 10.1007/BF00046347.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The case for therapeutic vaccines.

Melanoma Res. 1996 Feb;6(1):5-10. doi: 10.1097/00008390-199602000-00002.

Active immunotherapy with allogeneic tumor cell vaccines: present status.

Semin Oncol. 1998 Dec;25(6):611-22.

The development of therapeutic vaccines of the management of malignant melanoma.

Cancer Surv. 1996;26:289-319.

Does adjuvant vaccine therapy really have activity in malignant melanoma?

J Clin Oncol. 2007 Oct 10;25(29):4693; author reply 4693-5. doi: 10.1200/JCO.2007.13.3389.

Rational development of peptide vaccination in clinical oncology.

Onkologie. 2001 Apr;24(2):174. doi: 10.1159/000050308.

Cancer vaccines get a shot in the arm.

Science. 1993 Nov 5;262(5135):841-3. doi: 10.1126/science.8235605.

Immunotherapeutic approaches for the treatment of malignant melanoma.

Curr Opin Investig Drugs. 2001 Nov;2(11):1553-63.

Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine.

Semin Cancer Biol. 2003 Dec;13(6):409-15. doi: 10.1016/j.semcancer.2003.09.004.

Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal.

J Am Coll Surg. 2008 Jul;207(1):95-105. doi: 10.1016/j.jamcollsurg.2008.01.024. Epub 2008 May 23.

Melanoma and immunotherapy.

Hematol Oncol Clin North Am. 2009 Jun;23(3):547-64, ix-x. doi: 10.1016/j.hoc.2009.03.009.

引用本文的文献

Gene therapy of benign gynecological diseases.

Adv Drug Deliv Rev. 2009 Aug 10;61(10):822-35. doi: 10.1016/j.addr.2009.04.023. Epub 2009 May 13.

Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.

Cancer Immunol Immunother. 2007 Nov;56(11):1853-60. doi: 10.1007/s00262-007-0340-1. Epub 2007 Jun 5.

Potential applications of gene therapy in the patient with cancer.

Drugs Aging. 2000 Aug;17(2):121-32. doi: 10.2165/00002512-200017020-00004.

Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Cancer Metastasis Rev. 1996 Sep;15(3):351-64. doi: 10.1007/BF00046347.